missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD153 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen PA568434
Additional Details : Weight : 0.01000kg
Description
The ligand for CD30 is CD30L (CD153). The binding of CD30 to CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation, and apoptotic cell death. CD30 has a critical role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulatory molecule in thymic negative selection. In addition to its expression on Hodgkin's and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin's lymphomas (including Burkitt's lymphomas), virus-infected T and B cells, and on normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2-type cytokines and on CD4+/CD8+ thymocytes that coexpress CD45RO and the IL4 receptor.Specifications
CD153 | |
Polyclonal | |
Unconjugated | |
Tnfsf8 | |
CD153; CD153 antigen; CD30 antigen ligand; CD30 ligand; Cd30l; CD30-L; Cd30lg; CD30ligand; Tnfsf8; TNLG3A; tumor necrosis factor (ligand) superfamily member 8; tumor necrosis factor (ligand) superfamily, member 8; tumor necrosis factor ligand 3A; tumor necrosis factor ligand superfamily member 8; tumor necrosis factor superfamily member 8 | |
Rabbit | |
affinity chromatography | |
RUO | |
944 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.5 mg/mL | |
PBS with 40% glycerol and 0.05% sodium azide; pH 7.4 | |
P32971 | |
Tnfsf8 | |
Synthetic peptide corresponding to residues near the N terminal of human TNFSF8. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |